Kiniksa Pharmaceuticals : 2021 Annual Report
Every Second Counts! ANNUAL 20 REPORT 21 Dear Fellow Shareholders, ... | June 27, 2022
Source: marketscreener.com
Page 2 - Staff Comments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Staff Comments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Staff Comments Today - Breaking & Trending Today
4D pharma : Annual Report (SEC Filing - 20-F)
* Not for trading, but in connection with the registration of American Depositary Shares, pursuant to the requirements of the Securities and Exchange Commission. Securities registered or to be registered pursuant to Section 12(g) of the Act: None None Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report: Title of each class Ordinary Shares, nominal value £0.0025 per Share 131,467,935 Indicate by check mark if the registrant is a...
Source: marketscreener.com